Alaunos Therapeutics Inc (TCRT)
1.29
+0.03
(+2.38%)
USD |
NASDAQ |
May 01, 16:00
1.34
+0.05
(+3.88%)
After-Hours: 20:00
Alaunos Therapeutics Cash from Operations (TTM): -30.14M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -30.14M |
| September 30, 2023 | -29.89M |
| June 30, 2023 | -29.66M |
| March 31, 2023 | -30.84M |
| December 31, 2022 | -29.23M |
| September 30, 2022 | -37.23M |
| June 30, 2022 | -40.66M |
| March 31, 2022 | -53.92M |
| December 31, 2021 | -61.47M |
| September 30, 2021 | -63.38M |
| June 30, 2021 | -69.87M |
| March 31, 2021 | -62.42M |
| December 31, 2020 | -57.01M |
| September 30, 2020 | -51.58M |
| June 30, 2020 | -46.45M |
| March 31, 2020 | -40.53M |
| December 31, 2019 | -40.85M |
| September 30, 2019 | -41.06M |
| June 30, 2019 | -38.64M |
| March 31, 2019 | -40.73M |
| December 31, 2018 | -49.46M |
| September 30, 2018 | -49.79M |
| June 30, 2018 | -54.00M |
| March 31, 2018 | -59.35M |
| December 31, 2017 | -54.67M |
| Date | Value |
|---|---|
| September 30, 2017 | -55.58M |
| June 30, 2017 | -56.97M |
| March 31, 2017 | -56.52M |
| December 31, 2016 | -58.32M |
| September 30, 2016 | -69.06M |
| June 30, 2016 | -9.751M |
| March 31, 2016 | -6.372M |
| December 31, 2015 | -0.01M |
| September 30, 2015 | 13.92M |
| June 30, 2015 | -41.77M |
| March 31, 2015 | -37.71M |
| December 31, 2014 | -36.65M |
| September 30, 2014 | -35.82M |
| June 30, 2014 | -40.83M |
| March 31, 2014 | -49.92M |
| December 31, 2013 | -59.51M |
| September 30, 2013 | -71.96M |
| June 30, 2013 | -71.17M |
| March 31, 2013 | -71.22M |
| December 31, 2012 | -78.83M |
| September 30, 2012 | -71.08M |
| June 30, 2012 | -67.47M |
| March 31, 2012 | -56.53M |
| December 31, 2011 | -38.84M |
| September 30, 2011 | -30.87M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-69.87M
Minimum
Jun 2021
-29.23M
Maximum
Dec 2022
-44.99M
Average
-40.85M
Median
Dec 2019
Cash from Operations (TTM) Benchmarks
| NeuroBo Pharmaceuticals Inc | -10.80M |
| NovaBay Pharmaceuticals Inc | -4.131M |
| Palatin Technologies Inc | -26.54M |
| iBio Inc | -18.89M |
| Theriva Biologics Inc | -19.00M |